ALPHARETTA, Ga., July 21 /PRNewswire/ — EndoChoice, Inc.
today announced that it has moved its corporate headquarters to a
new location in Alpharetta,
Georgia. The new 30,000 square foot corporate
headquarters is three times larger than its previous facility, and
features a state-of-the-art GI anatomic pathology laboratory.
“We are very pleased with a seamless move into our new corporate
headquarters,” stated EndoChoice CEO and Founder Mark Gilreath. “With space for the
R&D of GI devices and supplies, and a GI specialty diagnostic
laboratory, our new facility highlights the complete focus on
endoscopy that makes EndoChoice truly unique to the medical
technology industry.”
EndoChoice Pathology is a national reference laboratory
accredited by the College of American Pathologists (CAP). The
GI specialty laboratory is led by Medical Director, Dr. Robert Smith. “Our recent lab
expansion and investments in technology enable EndoChoice to
provide unmatched service to the GI physician. It’s a very
exciting time for our company,” said Smith.
About EndoChoice, Inc.
EndoChoice designs, manufactures and markets innovative
solutions for professionals in gastrointestinal endoscopy
worldwide. Its diverse portfolio of high-quality devices,
supplies, equipment, and pathology services uniquely positions
EndoChoice as a leading resource for GI professionals. The
company strives to exceed its customers’ expectations through its
superior products, exemplary customer care, knowledgeable sales
force, and easy online ordering. For more information, visit
SOURCE
